Marcia Riley

Crystal structure of human fibrinogen.

A crystal structure of human fibrinogen has been determined at approximately 3.3 A resolution. The protein was purified from human blood plasma, first by a cold ethanol precipitation procedure and then by stepwise chromatography on DEAE-cellulose. A product was obtained that was homogeneous on SDS-polyacrylamide gels. Nonetheless, when individual crystals used for X-ray diffraction were examined by SDS gel electrophoresis after data collection, two species of alpha chain were present, indicating that some proteolysis had occurred during the course of operations. Amino-terminal sequencing on post-X-ray crystals showed mostly intact native alpha- and gamma-chain sequences (the native beta chain is blocked). The overall structure differs from that of a native fibrinogen from chicken blood and those reported for a partially proteolyzed bovine fibrinogen in the nature of twist in the coiled-coil regions, likely due to weak forces imparted by unique crystal packing. As such, the structure adds to the inventory of possible conformations that may occur in solution. Other features include a novel interface with an antiparallel arrangement of beta chains and a unique tangential association of coiled coils from neighboring molecules. The carbohydrate groups attached to beta chains are unusually prominent, the full sweep of 11 sugar residues being positioned. As was the case for native chicken fibrinogen, no resolvable electron density could be associated with alphaC domains.

Two families of synthetic peptides that enhance fibrin turbidity and delay fibrinolysis by different mechanisms.

When fibrin clots are formed in vitro in the presence of certain positively charged peptides, the turbidity is enhanced and fibrinolysis is delayed. Here we show that these two phenomena are not always linked and that different families of peptides bring about the delay of lysis in different ways. In the case of intrinsically adhesive peptides corresponding to certain regions of the fibrinogen gammaC and betaC domains, even though these peptides bind to fibrin(ogen) and enhance turbidity, the delay in lysis is mainly due to direct inhibition of plasminogen activation. In contrast, for certain pentapeptides patterned on fibrin B knobs, the delay in lysis is a consequence of how fibrin units assemble. On their own, these B knob surrogates can induce the gelation of fibrinogen molecules. The likely cause of enhanced clot turbidity and delay in fibrinolysis was revealed by a crystal structure of the D-dimer from human fibrinogen cocrystallized with GHRPYam, the packing of which showed the direct involvement of the ligand tyrosines in antiparallel betaC-betaC interactions.

Amino acid compositions of the subunit chains of lamprey fibrinogen. Evolutionary significance of some structural anomalies.

Our original objective in studying lamprey fibrinogen was embodied in the notion that the proteins of this ancient vertebrate might themselves by more primitive. As such, it was possible that the subunits of lamprey fibrinogen might have been more similar, one to another, than is the case in higher vertebrates, or even identical. Amino acid analysis of the individual polypeptide chains indicates, however, that the alpha, beta and gamma-chains are instead more dissimilar from each other than are the corresponding chains from human fibrinogen. This finding was somewhat surprising because regions of homology have been detected recently among those three chains when isolated from human fibrinogen, suggesting that all three chains have indeed descended from a common ancestor. The paradox is especially evidenced by the unusual amino acid composition of the lamprey alpha-chain, 45% of which is composed of glycine, serine and threonine. This unusual amino acid distribution may be involved in the anomalous behavior of these chains on sodium dodecyl sulfate polyacrylamide gel electrophoresis.